Syndax Pharmaceuticals Inc buy melinda
Start price
25.06.18
/
50%
€6.75
Target price
01.10.18
€9.02
Performance (%)
16.34%
End price
01.10.18
€7.85
Summary
This prediction ended on 01.10.18 with a price of €7.85. The BUY prediction by melinda finished with a performance of 16.34%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | - | - | -5.528% | 20.513% |
| iShares Core DAX® | 1.080% | -2.933% | 12.885% | 14.247% |
| iShares Nasdaq 100 | 0.362% | 7.015% | 36.826% | 57.151% |
| iShares Nikkei 225® | -1.155% | -1.155% | 5.073% | 3.799% |
| iShares S&P 500 | 0.806% | 4.388% | 30.269% | 49.772% |
According to melinda what are the pros and cons of Syndax Pharmaceuticals Inc for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Syndax Pharmaceuticals Inc diskutieren
SecteurProduits pharmaceutiques Agenda 08/08 Publication de résultats
Develops biopharmaceuticals for novel cancer therapies
Syndax Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer therapies.
Its products include candidate and entinostat.
The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.
Syndax Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer therapies.
Its products include candidate and entinostat.
The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.
Nombre d'employés : 45 personnes.
Stopped prediction by melinda for Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€15.90
17.09.23
17.09.23
-
17.09.24
17.09.24
1.26%
10.12.23
10.12.23
Could be worthwhile Investment >10% per year
Syndax Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€20.60
25.07.22
25.07.22
-
25.07.23
25.07.23
-7.28%
26.07.23
26.07.23
Could be worthwhile Investment >10% per year
Syndax Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€7.07
29.05.19
29.05.19
€9.02
02.07.19
02.07.19
15.43%
02.07.19
02.07.19
Could be worthwhile Investment >10% per year
Syndax Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€4.59
03.11.18
03.11.18
€5.86
11.01.19
11.01.19
28.29%
11.01.19
11.01.19
Could be worthwhile Investment >10% per year
Syndax Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€12.60
17.10.17
17.10.17
€15.00
27.12.17
27.12.17
-33.81%
27.12.17
27.12.17
Could be worthwhile Investment >10% per year
Syndax Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€11.37
17.10.17
17.10.17
€13.53
27.12.17
27.12.17
-33.81%
27.12.17
27.12.17
Could be worthwhile Investment >10% per year
Syndax Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€13.69
17.05.17
17.05.17
€6.86
30.05.17
30.05.17
-12.78%
30.05.17
30.05.17
Could be worthwhile Investment >10% per year
Syndax Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€7.10
10.05.17
10.05.17
€9.92
16.05.17
16.05.17
15.63%
16.05.17
16.05.17
Could be worthwhile Investment >10% per year